39.57
+1.57(+4.13%)
Currency In USD
| Previous Close | 38 |
| Open | 37.89 |
| Day High | 39.6 |
| Day Low | 37.88 |
| 52-Week High | 103.81 |
| 52-Week Low | 36.9 |
| Volume | 1.41M |
| Average Volume | 1.1M |
| Market Cap | 2.2B |
| PE | -25.69 |
| EPS | -1.54 |
| Moving Average 50 Days | 46.72 |
| Moving Average 200 Days | 61.74 |
| Change | 1.57 |
If you invested $1000 in PROCEPT BioRobotics Corporation (PRCT) since IPO date, it would be worth $943.49 as of September 17, 2025 at a share price of $39.57. Whereas If you bought $1000 worth of PROCEPT BioRobotics Corporation (PRCT) shares 3 years ago, it would be worth $955.1 as of September 17, 2025 at a share price of $39.57.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
GlobeNewswire Inc.
Jul 24, 2025 10:00 PM GMT
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
GlobeNewswire Inc.
Jul 23, 2025 12:00 PM GMT
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that thre
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire Inc.
Jul 21, 2025 8:03 PM GMT
SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it